Schiff, David
University of Virginia
12 papers on CoChatORCID 0000-0002-1896-2502
Most cited papers
- Verified
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., Colman, H., Chakravarti, A., Pugh, S., Won, M., et al. (2014) · New England Journal of Medicine
Glioma Diagnosis and TreatmentAngiogenesis and VEGF in Cancer
Cited by 2,834
- Verified
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology
Glioma Diagnosis and TreatmentOvarian cancer diagnosis and treatment
Cited by 1,168
- Verified
NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Stupp, R., Wong, E. T., Kanner, A. A., Steinberg, D., Engelhard, H., Heidecke, V., Kirson, E. D., Taillibert, S., Liebermann, F., Dbalý, V., et al. (2012) · European Journal of Cancer
Glioma Diagnosis and TreatmentElectromagnetic Fields and Biological Effects
Cited by 862
- Verified
MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes
Li, Y., Guessous, F., Zhang, Y., DiPierro, C., Kefas, B., Johnson, E., Marcinkiewicz, L., Jiang, J., Yang, Y., Schmittgen, T. D., et al. (2009) · Cancer Research
MicroRNA in disease regulationGlioma Diagnosis and Treatment
Cited by 614
- Verified
Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors.
Cook, D., Crowther, M., Meade, M., Rabbat, C., Griffith, L., Schiff, D., Geerts, W., & Guyatt, G. (2005) · Critical Care Medicine
Venous Thromboembolism Diagnosis and ManagementIntensive Care Unit Cognitive Disorders
Cited by 430
- Verified
Phase I Study of GRN1005 in Recurrent Malignant Glioma
Drappatz, J., Brenner, A., Wong, E. T., Eichler, A., Schiff, D., Groves, M. D., Mikkelsen, T., Rosenfeld, S., Sarantopoulos, J., Meyers, C. A., et al. (2013) · Clinical Cancer Research
Glioma Diagnosis and TreatmentNanoparticle-Based Drug Delivery
Cited by 190
- Verified
CODEL: Phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design
Jaeckle, K. A., Ballman, K. V., van den Bent, M., Giannini, C., Galanis, E., Brown, P. D., Jenkins, R. B., Cairncross, J. G., Wick, W., Weller, M., et al. (2021) · Neuro-Oncology
Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy
Cited by 119
- Verified
PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations
Li, Y., Guessous, F., Kwon, S., Kumar, M., Ibidapo, O., Fuller, L., Johnson, E., Lal, B., Hussaini, I., Bao, Y., et al. (2008) · Cancer Research
Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer
Cited by 95
- Verified
RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).
Gilbert, M. R., Dignam, J., Won, M., Blumenthal, D. T., Vogelbaum, M. A., Aldape, K. D., Colman, H., Chakravarti, A., Jeraj, R., Armstrong, T. S., et al. (2013) · Journal of Clinical Oncology
Glioma Diagnosis and TreatmentAngiogenesis and VEGF in Cancer
Cited by 70
- Verified
Treatment considerations for MGMT-unmethylated glioblastoma
Taylor, J. W., & Schiff, D. (2015) · Current Neurology and Neuroscience Reports
Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy
Cited by 60
- Verified
A novel PTEN/mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapy
Huang, X., Zhang, Y., Tang, Y., Butler, N., Kim, J., Guessous, F., Schiff, D., Mandell, J., & Abounader, R. (2013) · Neoplasia
Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer
Cited by 53
- Verified
Phase 2 and biomarker study of trebananib, an angiopoietin‐blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma
Reardon, D. A., Lassman, A. B., Schiff, D., Yunus, S. A., Gerstner, E. R., Cloughesy, T. F., Lee, E. Q., Gaffey, S. C., Barrs, J., Bruno, J., et al. (2018) · Cancer
Angiogenesis and VEGF in CancerGlioma Diagnosis and Treatment
Cited by 50
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free